About ImmunityBio, Inc. (IBRX) data
Data as of August 14, 2026.
ImmunityBio, Inc. (IBRX) has 127.50M shares sold short as of the latest FINRA settlement report on August 14, 2026. Short interest has decreased by 1.16% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 15.44 days (days to cover).
Recent IBRX short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Aug 14, 2026 | 127,495,672 | -1.16% | 15.44 |
| Jul 31, 2026 | 128,997,049 | -4.02% | 14.49 |
| Jul 15, 2026 | 134,395,641 | 1.95% | 11.92 |
| Jun 30, 2026 | 131,830,884 | -2.46% | 8.66 |
| Jun 15, 2026 | 135,149,785 | 2.28% | 11.95 |
| May 29, 2026 | 132,143,163 | -0.46% | 7.64 |
| May 15, 2026 | 132,753,919 | -3.88% | 10.57 |
| Apr 30, 2026 | 138,109,255 | -1.58% | 10.60 |
| Apr 15, 2026 | 140,326,066 | 3.53% | 9.54 |
| Mar 31, 2026 | 135,542,079 | 1.00% | 4.68 |
| Mar 13, 2026 | 134,199,301 | 1.33% | 5.26 |
| Feb 27, 2026 | 132,437,647 | -1.68% | 2.68 |
Full history, charts, and borrow-fee detail are on the IBRX short interest page.
Frequently asked questions
What is the current short interest in IBRX?
As of the latest FINRA settlement dated August 14, 2026, IBRX had approximately 127,495,672 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short IBRX?
The latest borrow fee (cost to borrow) for IBRX is 0.62% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for IBRX?
Days to cover for IBRX is approximately 15.44 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is IBRX a short squeeze candidate?
A squeeze needs shorts that are hard to close. IBRX trades about 8,258,532 shares a day and would take roughly 15.44 days to unwind current short positions, at a current borrow fee of 0.62%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.